Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 3NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Neoplasm Metastasis 2Carcinoma 2Adenocarcinoma 2Sarcoma, Ewing 1Gastrointestinal Stromal Tumors 1Colonic Neoplasms 1

Interventions

Vincristine 3Ifosfamide 3Etoposide 3Doxorubicin 3Cyclophosphamide 3Surgical Procedures, Operative 2Specimen Handling 2Radiotherapy 2Melphalan 2Irinotecan 2Busulfan 2regorafenib 1irinotecan sucrosofate 1X-Rays 1Trabectedin 1Temozolomide 1Radiation 1Phantoms, Imaging 1Magnetic Resonance Spectroscopy 1Fluorodeoxyglucose F18 1Dactinomycin 1Bone Density 1Biopsy 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Sarcoma, Ewing × regorafenib × Clear all
NCT06820957 2026-02-17

Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body

Children's Oncology Group

Phase 2/3 Active not recruiting
437 enrolled
Sarcoma

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡